XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT05005728 · COMPLETED
Trial details
- NCT number
- NCT05005728
- Sponsor
- Xencor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2025-06-10
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.